259 related articles for article (PubMed ID: 29249202)
1. Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination.
Virlogeux V; Zoulim F; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
BMC Med; 2017 Dec; 15(1):217. PubMed ID: 29249202
[TBL] [Abstract][Full Text] [Related]
2. Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018.
Cotte L; Hocqueloux L; Lefebvre M; Pradat P; Bani-Sadr F; Huleux T; Poizot-Martin I; Pugliese P; Rey D; Cabié A;
Clin Infect Dis; 2021 Nov; 73(9):e3266-e3274. PubMed ID: 33400777
[TBL] [Abstract][Full Text] [Related]
3. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
Pradat P; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
J Infect; 2017 Sep; 75(3):234-241. PubMed ID: 28579302
[TBL] [Abstract][Full Text] [Related]
4. Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights.
Martin NK; Thornton A; Hickman M; Sabin C; Nelson M; Cooke GS; Martin TCS; Delpech V; Ruf M; Price H; Azad Y; Thomson EC; Vickerman P
Clin Infect Dis; 2016 May; 62(9):1072-1080. PubMed ID: 26908813
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C treatment initiation in HIV-HCV coinfected patients.
Cotte L; Pugliese P; Valantin MA; Cuzin L; Billaud E; Duvivier C; Naqvi A; Cheret A; Rey D; Pradat P; Poizot-Martin I;
BMC Infect Dis; 2016 Jul; 16():345. PubMed ID: 27450098
[TBL] [Abstract][Full Text] [Related]
6. What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis.
Skaathun B; Borquez A; Rivero-Juarez A; Mehta SR; Tellez F; Castaño-Carracedo M; Merino D; Palacios R; Macías J; Rivero A; Martin NK
BMC Infect Dis; 2020 Aug; 20(1):588. PubMed ID: 32770955
[TBL] [Abstract][Full Text] [Related]
7. HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.
Martinello M; Hajarizadeh B; Grebely J; Dore GJ; Matthews GV
Curr HIV/AIDS Rep; 2017 Jun; 14(3):110-121. PubMed ID: 28432579
[TBL] [Abstract][Full Text] [Related]
8. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV;
AIDS; 2020 Jul; 34(9):1347-1358. PubMed ID: 32590433
[TBL] [Abstract][Full Text] [Related]
9. The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination.
Young J; Wang S; Lanièce Delaunay C; Cooper CL; Cox J; Gill MJ; Hull M; Walmsley S; Wong A; Klein MB;
Int J Drug Policy; 2023 Apr; 114():103981. PubMed ID: 36893502
[TBL] [Abstract][Full Text] [Related]
10. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.
Kronfli N; Nitulescu R; Cox J; Moodie EE; Wong A; Cooper C; Gill J; Walmsley S; Martel-Laferrière V; Hull MW; Klein MB;
J Int AIDS Soc; 2018 Nov; 21(11):e25197. PubMed ID: 30460791
[TBL] [Abstract][Full Text] [Related]
11. Eliminating HIV/HCV co-infection in gay and bisexual men: is it achievable through scaling up treatment?
Sacks-Davis R; Pedrana AE; Scott N; Doyle JS; Hellard ME
Expert Rev Anti Infect Ther; 2018 May; 16(5):411-422. PubMed ID: 29722275
[TBL] [Abstract][Full Text] [Related]
12. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.
Saeed S; Strumpf EC; Moodie EE; Young J; Nitulescu R; Cox J; Wong A; Walmsely S; Cooper C; Vachon ML; Martel-Laferriere V; Hull M; Conway B; Klein MB;
J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29116684
[TBL] [Abstract][Full Text] [Related]
13. HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men.
Adu PA; Rossi C; Binka M; Wong S; Wilton J; Wong J; Butt ZA; Bartlett S; Jeong D; Pearce M; Darvishian M; Yu A; Alvarez M; Velásquez García HA; Krajden M; Janjua NZ
Liver Int; 2021 Mar; 41(3):482-493. PubMed ID: 33305525
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs.
Socías ME; Ti L; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ
HIV Med; 2017 Oct; 18(9):647-654. PubMed ID: 28294492
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017.
Castry M; Cousien A; Bellet J; Champenois K; Pialoux G; Yazdanpanah Y; Costagliola D; Grabar S; Deuffic-Burban S;
Euro Surveill; 2021 Sep; 26(38):. PubMed ID: 34558403
[TBL] [Abstract][Full Text] [Related]
16. Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV.
Pradat P; Huleux T; Raffi F; Delobel P; Valantin MA; Poizot-Martin I; Pugliese P; Reynes J; Rey D; Hoen B; Cabie A; Bani-Sadr F; Cheret A; Duvivier C; Jacomet C; Fresard A; Hustache-Mathieu L; Cotte L;
AIDS; 2018 May; 32(8):1077-1082. PubMed ID: 29438195
[TBL] [Abstract][Full Text] [Related]
17. A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort Study.
Braun DL; Hampel B; Ledergerber B; Grube C; Nguyen H; Künzler-Heule P; Shah C; Salazar-Vizcaya L; Conen A; Flepp M; Stöckle M; Béguelin C; Schmid P; Rougemont M; Delaloye J; Bernasconi E; Nicca D; Böni J; Rauch A; Kouyos RD; Günthard HF; Fehr JS
Clin Infect Dis; 2021 Oct; 73(7):e2194-e2202. PubMed ID: 32761122
[TBL] [Abstract][Full Text] [Related]
18. HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.
Ingiliz P; Martin TC; Rodger A; Stellbrink HJ; Mauss S; Boesecke C; Mandorfer M; Bottero J; Baumgarten A; Bhagani S; Lacombe K; Nelson M; Rockstroh JK;
J Hepatol; 2017 Feb; 66(2):282-287. PubMed ID: 27650285
[TBL] [Abstract][Full Text] [Related]
19. Eliminating Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in Berlin: A Modeling Analysis.
Martin NK; Jansen K; An der Heiden M; Boesecke C; Boyd A; Schewe K; Baumgarten A; Lutz T; Christensen S; Thielen A; Mauss S; Rockstroh JK; Skaathun B; Ingiliz P
J Infect Dis; 2019 Oct; 220(10):1635-1644. PubMed ID: 31301142
[TBL] [Abstract][Full Text] [Related]
20. Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial.
Doyle JS; van Santen DK; Iser D; Sasadeusz J; O'Reilly M; Harney B; Traeger MW; Roney J; Cutts JC; Bowring AL; Winter R; Medland N; Fairley CK; Moore R; Tee BK; Asselin J; El-Hayek C; Hoy JF; Matthews GV; Prins M; Stoové MA; Hellard ME
Clin Infect Dis; 2021 Oct; 73(7):e2164-e2172. PubMed ID: 33010149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
